Pfizer Inc. faced a challenging day on the New York Stock Exchange, with its stock price dropping 2.1% to $29.57. Despite this setback, the pharmaceutical behemoth received positive news from a Phase ...
NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2024 of $0.21 per Class A ...
Results that may be inaccessible to you are currently showing.